Publications
- Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature2022 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK2022 | Second Faculty of Medicine
- Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing2022 | Second Faculty of Medicine
- Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining2021 | Second Faculty of Medicine, Faculty of Physical Education and Sport, First Faculty of Medicine
- Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence2021 | Second Faculty of Medicine, First Faculty of Medicine
- Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside2020 | Second Faculty of Medicine
- Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy2019 | Second Faculty of Medicine
- Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation2018 | Second Faculty of Medicine, First Faculty of Medicine
- Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects2018 | Second Faculty of Medicine
- An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia2017 | Second Faculty of Medicine, First Faculty of Medicine
Loading network view...
